Pharvaris NV Overview
Pharvaris NV Target Price
Analysts' 12-month price predictions for PHVS.
Get informed when a big investor buys or sells
+ FollowShare Price
$34.42
Average Target Price
$54.00
56.9% upside
56.9% upside3 analysts in the last 4 months
High: $74 | Low: $42
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-25 | Morgan StanleyMaxwell Skor | $46 | 33.6% upside |  |
| 2026-05-13 | UBS | $74 | 115% upside | |
| 2026-04-08 | Wolfe Research | $42 | 22% upside | |
| 2026-03-09 | RBC Capital | $52 | 51.1% upside | |
| 2025-12-04 | Oppenheimer | $50 | 45.3% upside | |
| 2025-12-04 | GuggenheimDebjit Chattopadhyay | $39 | 13.3% upside | |
| 2025-12-04 | Morgan StanleyMaxwell Skor | $41 | 19.1% upside | |
| 2025-12-03 | Leerink Partners | $38 | 10.4% upside | |
| 2025-10-15 | H.C. Wainwright | $60 | 74.3% upside | |
| 2024-10-14 | OppenheimerJustin Kim | $42 | 22% upside | |
| 2024-04-11 | JMP SecuritiesJonathan Wolleben | $50 | 45.3% upside | |
| 2023-09-25 | WedbushLaura Chico | $27 |  21.6% downside | |
| 2023-01-11 | JMP Securities | $23 | 33.2% downside | |
| 2022-12-09 | JMP Securities | $22 | 36.1% downside | |